1,25-dihydroxycholesterol treatment of long-term haemodialysed patients with renal osteodystrophy.

Renal osteodystrophy still poses major problems in the management of chronic renal failure, though it had been extensively studied over the last years. The present therapeutic possibilities - massive-dose vitamin D, aluminium hydroxide and supplementary Ca-intake, administration of active vitamin D metabolites - are discussed in the light of personal observations.